Full name
LIOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
10.89.Z - Production of other food products, not elsewhere classified
10.92.Z - Production of prepared pet food
20 - Manufacture of chemicals and chemical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.3 - Wholesale trade of food, beverages, and tobacco products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
86.90.D - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,6 | 1,7 | 171,2 |
EBITDA | 0 | 0,9 | 2,2 | 160 |
Short time liabilities | 0,3 | 1,3 | 1,3 | 3,1 |
Equity capital | 1,1 | 1,9 | 4,1 | 108,7 |
Operating profit (EBIT) | 0 | 0,8 | 2 | 163,7 |
Assets | 1,8 | 6,8 | 11,4 | 68,3 |
Net profit (loss) | 0 | 0,5 | 1,7 | 212,3 |
Cash | 0,2 | 0 | 0,1 | 319,8 |
Net income from sale | 2,4 | 6,1 | 8,9 | 47,2 |
Liabilities and provisions for liabilities | 0,8 | 4,9 | 7,4 | 52,2 |
Working assets | 1,2 | 1,3 | 2,5 | 89,6 |
Depreciation | 0 | 0,1 | 0,3 | 134,3 |
% | % | % | p.p. | |
Profitability of capital | 0,1 | 28,3 | 42,3 | 14 |
Equity capital to total assets | 58,3 | 28,6 | 35,5 | 6,9 |
Gross profit margin | 0,1 | 10,5 | 19,3 | 8,8 |
EBITDA Margin | 0,4 | 14,2 | 25 | 10,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 40 | 79 | 55 | -24 |
Current financial liquidity indicator | 4.608123779296875 | 0.8265440464019775 | 1.5543808937072754 | 0,8 |
Net dept to EBITDA | 39.32522201538086 | 4.1355695724487305 | 2.8199803829193115 | -1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane